This inventor holds 1 USPTO granted patent. Top assignee: Tokyo Metropolitan Institute of Medical Science. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Kazunari Sekiyama: Innovator in Neurodegenerative Disease Treatment
Introduction
Kazunari Sekiyama is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical science, particularly in the treatment and prevention of neurodegenerative diseases. His innovative approach focuses on the use of adiponectin receptor agonists to combat these challenging conditions.
Latest Patents
Kazunari Sekiyama holds a patent for a method aimed at treating and/or preventing neurodegenerative diseases through the use of adiponectin receptor agonists. This invention is based on the discovery that these agonists can suppress α (alpha)-synuclein aggregation, tau phosphorylation, and a decrease in proteasomal activity. The method involves administering an effective dose of at least one element selected from a group that includes adiponectin, compounds inducing the expression of adiponectin, globular adiponectin, and compounds inducing the expression of globular adiponectin. Additionally, the patent provides a screening method for identifying adiponectin receptor agonists suitable for treating and/or preventing neurodegenerative diseases. Kazunari Sekiyama has 1 patent to his name.
Career Highlights
Kazunari Sekiyama is affiliated with the Tokyo Metropolitan Institute of Medical Science, where he conducts his research and development work. His career is marked by a commitment to advancing medical science and improving treatment options for patients suffering from neurodegenerative diseases.
Collaborations
Throughout his career, Kazunari Sekiyama has collaborated with notable colleagues, including Akio Sekigawa and Masayo Fujita. These collaborations have contributed to the advancement of research in the field and have fostered a collaborative environment for innovation.
Conclusion
Kazunari Sekiyama's work in developing methods for treating neurodegenerative diseases showcases his dedication to medical innovation. His contributions are vital in the ongoing fight against these complex conditions, and his research continues to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile